4//SEC Filing
Conover Charles 4
Accession 0001144204-13-004103
CIK 0000727510other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 6:11 PM ET
Size
6.2 KB
Accession
0001144204-13-004103
Insider Transaction Report
Form 4
Conover Charles
SVP, R&D Program Management
Transactions
- Award
Common Stock
2013-01-23+2,343→ 74,793 total
Footnotes (2)
- [F1]This Form 4 is being filed to report the accelerated vesting of 2,343 restricted stock units (RSUs) that were originally granted to the Reporting Person on August 12, 2011. The August 12, 2011 grant consisted of 7,028 RSUs, which vest in full on August 12, 2014 if the Reporting Person remains employed by the Issuer on such date, provided that 50% of the RSUs are subject to accelerated vesting upon the achievement of certain performance milestones. Certain of the performance milestones applicable to the RSU grant were achieved, resulting in the accelerated vesting of 2,343 of the RSUs on January 23, 2013.
- [F2]Because the RSUs granted to the Reporting Person on August 12, 2011 were previously included in the number of shares of common stock reported as beneficially owned by the Reporting Person, the accelerated vesting of 2,343 of the RSUs did not affect the number of shares reported as beneficially owned.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001538563
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 6:11 PM ET
- Size
- 6.2 KB